Gustel Lifescience Private Limited

Gustel Lifescience Private Limited

Manufactures medicines with registered office in Jaipur, Rajasthan.
2012 | Jaipur, Rajasthan (India) | Active

Last Updated:

December 16, 2024
HomeCompanyGustel Lifescience Private Limited

Who are the key members and board of directors at Gustel Lifescience?

Board Members(2)

NameDesignationAppointment DateStatus
Sharma Pulkit In Director 04-May-2012Current
Madhukar Sharma In Additional Director 02-Sep-2022Current

Financial Performance of Gustel Lifescience.

Gustel Lifescience Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.57% decrease. The company also saw a substantial fall in profitability, with a 3169.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.68%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-39.57%
Revenue from Operations
-39.94%
Total Assets
27.88%
Profit or Loss
-3169.39%
Net Worth
-21.68%
EBITDA
-69.46%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹9.50 M

LenderAmountStatus

Bank Of Baroda

Creation Date: 15 Oct 2013
₹9.50 MOpen

How Many Employees Work at Gustel Lifescience?

Unlock and access historical data on people associated with Gustel Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Gustel Lifescience

Recent activity within the organization

  • Director Appointment

    Madhukar Sharma was appointed as a Additional Director was appointed as a Additional Director on 02 Sep 2022 & has been associated with this company since 2 years 3 months .

    02 Sep 2022

  • Annual General Meeting

    Gustel Lifescience Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.

    30 Nov 2021

  • Balance Sheet

    Gustel Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Jaipur.

    31 Mar 2021

  • Charges

    A charge with Bank Of Baroda amounted to Rs. 9.50 M with Charge ID 10456411 was registered on 15 Oct 2013.

    15 Oct 2013

  • Director Appointment

    Sharma Pulkit was appointed as a Director was appointed as a Director on 04 May 2012 & has been associated with this company since 12 years 7 months .

    04 May 2012

  • Company Incorporation

    Gustel Lifescience Private Limited was registered on 04 May 2012 with Roc Jaipur & aged 12 years 7 months as per MCA records.

    04 May 2012

Frequently asked questions

  • Gustel Lifescience Private Limited was incorporated on 04 May 2012.

  • The authorized share capital of Gustel Lifescience Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Gustel Lifescience Private Limited.

    • Sharma Pulkit
    • Madhukar Sharma
  • As per Ministry of Corporate Affairs (Mca), the registered address of Gustel Lifescience Private Limited is C-2, Dev Nagar Tonk Road India, Jaipur, Rajasthan, 302018.

  • The corporate identification number (CIN) of Gustel Lifescience Private Limited is U24232RJ2012PTC038821 and the company number is 038821 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Gustel Lifescience Private Limited has fallen by -39.57%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Gustel Lifescience Private Limited has experienced an downturn of -21.68%.

  • As per the financial statements for fiscal Year 2020, The total open charges for Gustel Lifescience Private Limited amount to ₹ 9.50 M.

  • The most recent Balance Sheet for Gustel Lifescience Private Limited was filed with the ROC on 31 Mar 2021.

People also Viewed

Similar Companies Based on Drug Formulation & Development